🔬 Berylliosis · Chronic Beryllium Disease (CBD)

Nelson Textbook of Pediatrics 22nd Edition | Occupational granulomatous lung disease caused by beryllium exposure. High-risk industries: beryllium alloy production, nuclear weapons, aerospace, dental, electronics. Presents similar to sarcoidosis (noncaseating granulomas). Diagnosis: beryllium lymphocyte proliferation test (BeLPT) positive (most specific). Treatment: antigen avoidance (remove from exposure) is most important, corticosteroids for symptomatic disease. Prevention: workplace controls, medical surveillance.

🌐 paeds.online — Pakistan's Pediatric Platform

📋 30 Clinical Scenarios — Berylliosis (Chronic Beryllium Disease)

📇 High‑Yield Cards: Berylliosis (Chap 448.3)

🩺 Interactive Clinical Approach: Suspected Berylliosis

Select a presentation for diagnostic and management approach.

📋 Stepwise Management of Berylliosis

    InterventionKey Points
    Most Important: Remove from beryllium exposure
    Antigen avoidanceTransfer to non-beryllium work area or job change. Secondary exposure prevention (family members).
    CorticosteroidsFor symptomatic disease (dyspnea, cough, declining PFTs). Prednisone 0.5-1 mg/kg/day, taper to lowest effective dose.
    MonitoringSerial PFTs (every 6-12 months), CXR/HRCT, BeLPT (for diagnosis, not monitoring).
    Workplace surveillanceBeLPT screening for at-risk workers. Medical removal protection programs.

    ⚡ Reflex Prompts — Berylliosis Recognition & Management

    📖 Summary: Berylliosis — Nelson 22nd Ed